CN101961401A - Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying - Google Patents
Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying Download PDFInfo
- Publication number
- CN101961401A CN101961401A CN 201010275230 CN201010275230A CN101961401A CN 101961401 A CN101961401 A CN 101961401A CN 201010275230 CN201010275230 CN 201010275230 CN 201010275230 A CN201010275230 A CN 201010275230A CN 101961401 A CN101961401 A CN 101961401A
- Authority
- CN
- China
- Prior art keywords
- reducing
- parts
- group
- medicine
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound Chinese medicinal composition having the effects of reducing weight, reducing fat, tonifying spleen and beautifying. The composition comprises the following raw materials: 1 to 6 parts of lotus leaf, 1 to 6 parts of seaweed, 0.1 to 3 parts of rose, 0.5 to 4 parts of astragalus, 0.5 to 4 parts of largehead atractylodes rhizome, 0.5 to 4 parts of Indian buead and 0.1 to 3 parts of hawthorn. The composition has the effects of reducing weight, reducing fat, tonifying spleen and reducing body weight, can regulate blood and vitality and promote the blood circulation so as to fulfill the effects of beautifying and has the advantages of safety, convenience, no toxic or side effect and low cost.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of herbal mixture compositions with Weight-reducing and lipid-lowering spleen invigorating beauty functions.
Background technology
Under the fast development of global economy, human meals, nutriture have had tangible improvement.But severeer problem thereupon having occurred is that trophic structure is unbalance---obesity, excess fat is piled up very big to people's health hazard around subcutaneous and internal organs, shows that mainly coronary heart disease, hypertension, diabetes etc. easily take place the overweight people.Obesity has been classified as one of five big diseases of serious harm human health by World Health Organization (WHO), become human main " the social medicine problem " that faces in the new century.
Miscellaneous fat-reducing dietic medicinal is arranged in the market, but great majority all are chemicals, the medicine that has can bring some obvious toxic and side effects, for example can produce hepatic injury in various degree, occurs such as symptoms such as diarrhoea, dizziness, vomiting, anorexia; The synthetic class poisonous side effect of medicine that has is little, but poor effect and bounce-back easily; Herbal mixture also has a variety of, but wherein contains purgatives medicines such as similar Radix Et Rhizoma Rhei, Rhizoma Alismatis mostly, easily causes the insufficiency of the spleen and deficiency of vital energy.At above-mentioned problems of the prior art and defective, the objective of the invention is to for obese people provides a kind of Weight-reducing and lipid-lowering and the herbal mixture compositions of spleen invigorating beauty functions is arranged, said composition is evident in efficacy, safe ready, have no side effect and with low cost.
Summary of the invention
The technical scheme that realizes the foregoing invention purpose is a kind of herbal mixture compositions with Weight-reducing and lipid-lowering spleen invigorating beauty functions.The present invention is made by the following weight proportion raw material:
0.1～3 part of 1～6 portion of Flos Rosae Rugosae of 1～6 portion of Sargassum of Folium Nelumbinis
0.5～4 part in 0.5～4 part of Poria of 0.5～4 part of Rhizoma Atractylodis Macrocephalae of the Radix Astragali
0.1～3 part of Fructus Crataegi.
The weight proportion of each raw material of optimization formula of the present invention is:
0.3～1.5 part of 2～4 portions of Flos Rosae Rugosae of 2～4 portions of Sargassums of Folium Nelumbinis
1～2.5 part in 1～2.5 part of Poria of 1～2.5 part of Rhizoma Atractylodis Macrocephalae of the Radix Astragali
0.3～1.5 part of Fructus Crataegi.
The weight proportion of each raw material of optimum formula of the present invention is:
1 part of 3 portions of Flos Rosae Rugosae of 3 portions of Sargassums of Folium Nelumbinis
2 parts in 2 parts of Poria of 2 parts of Rhizoma Atractylodis Macrocephalaes of the Radix Astragali
1 part of Fructus Crataegi.
In more than forming, the weight of medicine is calculated with crude drug, with weight portion as proportioning, when producing, can proportionally increase or reduce, as large-scale production can be unit with the kilogram, or is unit with the ton, and small-scale production can be a unit with gram or milligram also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The ratio of above weight proportion obtains through science screening, and the proportioning of the amount of can corresponding adjustment forming increases or reduce being no more than 100%, and drug effect is constant.
Drug action mechanism among the present invention is as follows:
About the pathomechanism of obesity, ancient Chinese medicine doctor think with the deficiency of vital energy, expectorant, wet, become silted up relevant.The traditional Chinese medical science thinks that main pathogenesis is an overabundant YIN leading to insufficient YANG, and being embodied in the deficiency of vital energy and being yang deficiency is this, and excess of YIN is that water is wet, heresy of accumulation of phlegm in the hypochondrium, lipid turbid yin is mark, and wherein mainly to lack of proper care with the spleen renal function again be pathologic basis to the deficiency of vital energy, deficiency in origin and excess in superficiality.Simulataneous insufficiency and excessive.And among the deficiency of vital energy, especially with the deficiency of both the splenic and pulmonary QI person for seeing more, have a liking for food delicious food, rich and fatty diet, or flat rope do not get enough athletic exercise, or the old deficiency of YIN etc. all easily causes deficiency of both the splenic and pulmonary QI, deficiency of spleen-QI, then can not fortune transfer; Insufficiency of lung-QI then can not be declared and be sent out compress, causes the retention stagnation in vivo of essence derived from food and body fluid, and blood forms cream fat phlegm-damp, holds in skin, sends out to fat.Therefore one aspect of the present invention is lost weight the Sargassum blood fat reducing by Folium Nelumbinis; On the other hand, lose weight by the spleen invigorating QI invigorating effect of the Radix Astragali.
Monarch drug: the medicine that plays main therapeutical effect in the prescription at main symptom.
Folium Nelumbinis, property of medicine hardship, puckery, flat.GUIXIN, liver, spleen channel.Has clearing away summer-heat, yang invigorating, hemostatic effect.Can treat the summer-heat excessive thirst, it is dizzy to have a headache, splenasthenic abdominal distention, loose stool and diarrhea, haematemesis hematochezia, post partum longtime lochia, red trip erysipelas etc.(the 2510th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).Compendium of Material Medica is carried: " Folium Nelumbinis is obeyed it, makes us thin bad, single clothes can disappear the gas of YANG edema edema ".This Chinese medicine composition mainly with its as the fat-reducing principal agent.
Sargassum is rich in alginic acid, and it can reduce the intravital cholesterol of people.Consume by absorption and the promotion liver inner cholesterol that hinders cholesterol, played good effect for reducing blood fat.
Flos Rosae Rugosae, sweet, little hardship, temperature.Return liver, spleen channel.Can promoting QI circulation for relieving depression, and blood, pain relieving.Be used for stomachache due to hyperactive liver-QI attacking the stomach, the lack of appetite vomiting and nausea falls and pounces on the pain of injury (" Chinese pharmacopoeia).The effect that functions of improving blood circulation and face-beautifying is arranged.
Ministerial drug: auxiliary monarch drug is treated main symptom, or mainly treats the medicine of accompanied symptoms.
The Radix Astragali, slightly warm in nature, sweet in the mouth is returned spleen, lung meridian, functions such as tool spleen invigorating invigorating middle warmer, ascending up spleen-Qi and Yang, benefiting QI for strengthening the superficies, diuresis; Be used for temper and lose fatigue and weakness, anorexia and loose stool, edema due to the void, quench one's thirst, disease such as exterior deficiency spontaneous perspiration, cough with asthma due to the insufficiency of lung-QI.It extensively applies to clinical, has the organism metabolism of promotion, resisting fatigue, promotion serum and the proteinic regeneration function of liver; Can strengthen myocardial contraction, the protection cardiovascular system, arrhythmia, brings high blood pressure down, reduces platelet adhesion reaction power at coronary artery dilator and external perihaemal canal, blood fat reducing, thereby reduces thrombosis.
Adjuvant drug: monarch-minister drug treatment accompanied symptoms is closed in the assistant assignment.
The Rhizoma Atractylodis Macrocephalae, nature and flavor hardship, sweet, warm.Return spleen, stomach warp.Have invigorating the spleen and replenishing QI, the dampness diuresis and in antiabortive, strengthening superficial resistance to stop perspiration, anticancer effect.Can treat that pulmonary carcinoma, gastric cancer, cervical cancer, insufficiency of the spleen lack of appetite, abdominal distention are had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement, asthma, phlegmatic cough, leucorrhea, nebulousurine, seminal emission, gonorrhea, frequent micturition etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 447th page).
Poria, the property of medicine is sweet, light, and is flat.GUIXIN, spleen, lung, kidney channel.Has promoting diuresis to eliminate damp pathogen, invigorating the spleen and regulating the stomach, the effect of mind tranquilizing and the heart calming.Can treat dysuria, the edema distension, is had loose bowels at phlegm retention cough with dyspnea, vomiting, insufficiency of the spleen lack of appetite, palpitation and restlessness, insomnia forgetfulness, seminal emission nebulousurine etc.(the 2154th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The bitter temperature of the Rhizoma Atractylodis Macrocephalae and be good at dampness, Poria is sweet light and be good at eliminating dampness by diuresis, closes and use it, and one dry one oozes, and spleen invigorating dehumidifies, and complements each other.
Messenger drug: make to guide and lead the through diseased region of all medicines, or the medicine of coordinating the actions of various ingredients in a prescription.
Fructus Crataegi, property of medicine acid, sweet, tepor.Return spleen, stomach, Liver Channel.Has promoting digestion and invigorating the stomach, the effect of the diffusing addiction of circulation of qi promoting.Can treat eating accumulation, take off abdominal distention and pain, diarrhea dysentery, amenorrhea, puerperal abdonimal pain, lochiorrhea, skin ulcer gas or emerald green ball swell and ache hyperlipidemia etc.(the 226th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Preparation method of the present invention can adopt traditional traditional Chinese medical science decoction method to obtain taking for the people behind the extract.50～the 100g that gets it filled according to the above ratio earlier puts into the container of decocting herb after the mixing.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations.For example the extractum powder uniform mixing of these crude drug can be made medicinal tea.The active component of medicine of the present invention also can add various conventional adjuvant required when preparing different dosage form, method of Chinese medicinal as routines such as disintegrating agent, lubricant, binding agents is prepared into any peroral dosage form commonly used, as granule, pill, powder, tablet, capsule and oral liquid etc.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of " Ministry of Public Health is about the notice of further standard healthy food material management ", utilizes the comprehensive function fat-reducing of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, be rich in glucose among the present invention, organic acid, vitamin, various trace elements such as aminoacid are beneficial to absorption of human body, health invigorating.
3, the present invention has simple for production, taking convenience, cheap characteristics.
The specific embodiment:
Experimental verification:
1, it is long to measure body weight (starting weight and heavy eventually) and the body respectively organize before and after the mice administration respectively, calculates the Li Si index (seeing Table) of administration front and back.
It is as shown in the table, and each organizes the mice body weight all growth; Except that common group, this index of little Fructus rhamni (Rhamnus davurica Pall.) of II～V group all increases to some extent, has significance (P＜0.01) with respect to common group; For hyperlipidemia model group II, III, IV, V organize Li Si index relatively low (P＜0.05); And difference is not remarkable between III, IV, the V group.Show that the bent name group of medicine of the present invention and western cloth has same reduction effect to the Li Si index of mice.
Table one is respectively organized body weight and the Li Si index before and after the mice administration
Annotate: compare ▲ P＜0.01 with common matched group; Compare * P＜0.01, #P＜0.05 with model control group; Compare with positive controls, ◆ P＞0.05.
2, behind the gastric infusion 30d, pluck the eyeball method and collect blood, handle obtain serum after, record with ultraviolet spectrophotometer and respectively to organize TG in the mice serum, CHO, HDL-C concentration value (seeing Table two).
Data show in the table, the TG of hyperlipidemia model group, TCH and HDL-C concentration level are significantly higher than common matched group (P＜0.05), then make the fat model success of mice hyperlipidemia from the lipid aspects explanation.The TG level: positive controls significantly is lower than other groups (P＜0.05), and but the medicine group is higher than the III group is lower than I, II group (P＜0.05); The TCH level: bent of western cloth is organized and significantly is lower than hyperlipidemia model group (P＜0.05), and medicine IV group and III group difference not remarkable (P＞0.05) still significantly are lower than hyperlipidemia model group (P＜0.05); The HDL-C concentration level: with respect to the hyperlipidemia model group, III, IV, V significantly reduce (P＜0.05) for three groups, and wherein the hyperlipidemia model group is the highest, and the medicine group is lower than hyperlipidemia model group (P＜0.05), but is higher than I, II group (P＜0.01).Show that the present invention has the effect of blood fat reducing preferably.
Table two is respectively organized the blood lipid level after the mice administration
Annotate: compare ▲ P＜0.01, * P＜0.05 with common matched group; Compare with the hyperlipidemia model group,
P＜0.05; Compare with the bent name group of western cloth, ◆ P＜0.05, ★ P＞0.05.
3, successive administration 30d surveyed the mice body weight in per three days, and the administration front and back respectively organize the mice body weight and the body weight change situation sees Table three.
Data show in the table, hyperlipidemia model group body weight gain rate is in the II～V group of raising with high lipid food maximum (P＜0.01), and the bent name of western cloth is organized and common group of difference little (P＞0.05), and medicine group body weight gain rate significantly is lower than II, III group.The body weight gain rate has reflected obese degree to a certain extent, and visible medicine of the present invention has fat-reducing effect.
Table three is respectively organized the body weight gain rate before and after the mice administration
Annotate: compare with common matched group, ▲ P＜0.01,
P＜0.05; Compare * P＜0.01, #P＜0.05 with the hyperlipidemia model group; Compare with the bent name group of western cloth, ◆ P＜0.05.
4, behind the administration 30d, put to death mice, get abdominal part mesentery and perirenal fat pad, the weighing fat weight also calculates the fat coefficient (seeing Table four) of respectively organizing mice.
It is as shown in the table, compares with common matched group, and II～V group all has significance (P＜0.05).Compare with hyperlipidemia model group mice, the fat coefficient significance little (P＞0.05) of the bent name group of western cloth, and be far longer than common group; And medicine group (IV, V) all is lower than II, III group (P＜0.05) but is higher than I group.Show that this medicine can reduce body fat weight, has the effect of fat-reducing.
Table four is respectively organized the fat coefficient after the mice administration
Annotate: compare * P＜0.05 with common matched group; Compare ▲ P＜0.05, #P＞0.05 with the hyperlipidemia model group;
5, respectively organizing the mice physiology and the mental status during the administration observes
The mental status is good on ordinary days for common group of mice; Hair color is moist, cleaning; It is normal to get food drinking-water; Feces is normal.Hyperlipidemia model group mice is listless, and is drowsiness, do not like motion; Hair color is jaundice slightly, greasy cluster; To not good, feces is normal from vigorous for appetite.The bent name group of west cloth lethargy is depressed, drowsiness, not active; The hair color jaundice, greasy cluster; Inappetence; The feces color is shallow.The medicine group mental status is good; Hair color is moist, and is clean neat; It is normal to get food drinking-water; The feces color depth.Show medicine of the present invention to body without any toxic and side effects, the bent name of the western cloth stronger with respect to side effect, safety is higher.
6, behind the mice fasting 16h, 30min pours into medicine before each group experiment, and mice is put into the about 30cm of the diameter that fills water, in the bucket of about deeply 40cm, and the about 20cm of the depth of water, 28 ℃ of water temperatures.When mice swims in the water to overtired motionless, the nostril is judged to when just being submerged under water is drowned.The time that the mice entry is experienced to being drowned is as the endurance test index.Respectively organize the swimming time (see Table five) of mice in fatigue test after the administration.
The swimming time of data show medicine group is far longer than hyperlipidemia model group and the bent name group of western cloth (P＜0.01) in the table, illustrates that this medicine has good spleen invigorating effect, can prolong the mice endurance time.
Respectively organize the swimming time of mice after table five administration
Annotate: compare ▲ P＜0.05 with common matched group; Compare with the hyperlipidemia model group,
P＜0.05; Compare with the bent name group of western cloth, ◆ P＜0.01.
Below, by embodiment the present invention is described more specifically.But scope of the present invention is not limited in these embodiment.
Embodiment 1
Take by weighing raw material (unit: g) by following proportioning
Folium Nelumbinis 30, Sargassum 30, Flos Rosae Rugosae 10, the Radix Astragali 20, the Rhizoma Atractylodis Macrocephalae 20, Poria 20, Fructus Crataegi 10.
Medicine is cleaned, and mixing is fried boiling, decoct medicinal herbs twice, and each 1h, it is to add the dry powder that adjuvant was made 100 mesh sieves behind the extractum that filtering residue extracting juice, gained liquid are lower than 55 ℃ of dryings, the pack of sterilization final vacuum both got.Get final product with the warm water Instant Drinks when needing.
Embodiment 2
Take by weighing raw material (unit: g) by following proportioning
Folium Nelumbinis 20, Sargassum 40, Flos Rosae Rugosae 5, the Radix Astragali 25, the Rhizoma Atractylodis Macrocephalae 25, Poria 25, Fructus Crataegi 5.
Medicine is cleaned, and mixing is fried boiling, decoct medicinal herbs twice, and each 1h, it is to add the dry powder that adjuvant was made 100 mesh sieves behind the extractum that filtering residue extracting juice, gained liquid are lower than 55 ℃ of dryings, sterilization back fill capsule both got.
Embodiment 3
Take by weighing raw material (unit: g) by following proportioning
Folium Nelumbinis 10, Sargassum 50, Flos Rosae Rugosae 10, the Radix Astragali 10, the Rhizoma Atractylodis Macrocephalae 30, Poria 30, Fructus Crataegi 10.
Medicine is cleaned, and mixing is fried boiling, decoct medicinal herbs twice, and each 1h, it is to add the dry powder that adjuvant was made 100 mesh sieves behind the extractum that filtering residue extracting juice, gained liquid are lower than 55 ℃ of dryings, adds adjuvant and makes pill and get final product.
Embodiment 4
Take by weighing raw material (unit: g) by following proportioning
Folium Nelumbinis 40, Sargassum 20, Flos Rosae Rugosae 10, the Radix Astragali 40, the Rhizoma Atractylodis Macrocephalae 15, Poria 15, Fructus Crataegi 10.
Medicine is cleaned, and mixing is fried boiling, decoct medicinal herbs twice, and each 1h, it is to add the dry powder that adjuvant was made 100 mesh sieves behind the extractum that filtering residue extracting juice, gained liquid are lower than 55 ℃ of dryings, the pack of sterilization final vacuum both got.Get final product with the warm water Instant Drinks when needing.
Embodiment 5
Take by weighing raw material (unit: g) by following proportioning
Folium Nelumbinis 50, Sargassum 10, Flos Rosae Rugosae 10, the Radix Astragali 20, the Rhizoma Atractylodis Macrocephalae 10, Poria 10, Fructus Crataegi 10.
Embodiment 6
Take by weighing raw material (unit: kg) by following proportioning
Folium Nelumbinis 60, Sargassum 60, Flos Rosae Rugosae 15, the Radix Astragali 5, the Rhizoma Atractylodis Macrocephalae 5, Poria 5, Fructus Crataegi 15.
Embodiment 7
Take by weighing raw material (unit: g) by following proportioning
Folium Nelumbinis 20, Sargassum 40, Flos Rosae Rugosae 10, the Radix Astragali 40, the Rhizoma Atractylodis Macrocephalae 15, Poria 15, Fructus Crataegi 10.
Claims (3)
1. herbal mixture compositions with Weight-reducing and lipid-lowering spleen invigorating beauty functions is characterized in that it is made by the following weight proportion raw material:
0.1～3 part of 1～6 portion of Flos Rosae Rugosae of 1～6 portion of Sargassum of Folium Nelumbinis
0.5～4 part in 0.5～4 part of Poria of 0.5～4 part of Rhizoma Atractylodis Macrocephalae of the Radix Astragali
0.1～3 part of Fructus Crataegi.
2. the herbal mixture compositions with Weight-reducing and lipid-lowering spleen invigorating beauty functions according to claim 1 is characterized in that it is made by the following weight proportion raw material:
0.3～1.5 part of 2～4 portions of Flos Rosae Rugosae of 2～4 portions of Sargassums of Folium Nelumbinis
1～2.5 part in 1～2.5 part of Poria of 1～2.5 part of Rhizoma Atractylodis Macrocephalae of the Radix Astragali
0.3～1.5 part of Fructus Crataegi.
3. the herbal mixture compositions with Weight-reducing and lipid-lowering spleen invigorating beauty functions according to claim 1 is characterized in that it is made by the following weight proportion raw material:
1 part of 3 portions of Flos Rosae Rugosae of 3 portions of Sargassums of Folium Nelumbinis
2 parts in 2 parts of Poria of 2 parts of Rhizoma Atractylodis Macrocephalaes of the Radix Astragali
1 part of Fructus Crataegi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102752300A CN101961401B (en) | 2010-09-07 | 2010-09-07 | Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102752300A CN101961401B (en) | 2010-09-07 | 2010-09-07 | Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101961401A true CN101961401A (en) | 2011-02-02 |
| CN101961401B CN101961401B (en) | 2012-05-09 |
Family
ID=43514575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102752300A Expired - Fee Related CN101961401B (en) | 2010-09-07 | 2010-09-07 | Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101961401B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906509A (en) * | 2015-06-09 | 2015-09-16 | 林加五 | Medicine for treating hyperplasia of mammary glands |
| CN105919128A (en) * | 2016-04-29 | 2016-09-07 | 绍兴文理学院 | Whitening weight-reducing ostrich meat medicinal diet and preparation method thereof |
| CN106389718A (en) * | 2016-06-22 | 2017-02-15 | 王伟 | Method for preparing weight-losing drug |
| CN110168656A (en) * | 2017-10-23 | 2019-08-23 | 我利生命工学株式会社 | Traditional Chinese medicine capable of reducing weight management system and its method |
| CN113230320A (en) * | 2021-05-22 | 2021-08-10 | 韩艺 | Umbilical dropping liquid for losing weight and preparation method thereof |
| CN114869940A (en) * | 2022-03-29 | 2022-08-09 | 郗瑞席 | Traditional Chinese medicine composition, granules, water-bindered pills and method for treating hypertension, hyperlipidemia and hyperglycemia caused by obesity |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1422654A (en) * | 2002-12-16 | 2003-06-11 | 石羽 | Chinese medicine fat-reducing liniment and preparation method thereof |
-
2010
- 2010-09-07 CN CN2010102752300A patent/CN101961401B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1422654A (en) * | 2002-12-16 | 2003-06-11 | 石羽 | Chinese medicine fat-reducing liniment and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 《药膳食疗》 20021031 陈德兴等 荷叶在降脂减肥食疗制剂中的应用 5-9 1-3 , 第10期 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104906509A (en) * | 2015-06-09 | 2015-09-16 | 林加五 | Medicine for treating hyperplasia of mammary glands |
| CN105919128A (en) * | 2016-04-29 | 2016-09-07 | 绍兴文理学院 | Whitening weight-reducing ostrich meat medicinal diet and preparation method thereof |
| CN106389718A (en) * | 2016-06-22 | 2017-02-15 | 王伟 | Method for preparing weight-losing drug |
| CN110168656A (en) * | 2017-10-23 | 2019-08-23 | 我利生命工学株式会社 | Traditional Chinese medicine capable of reducing weight management system and its method |
| CN113230320A (en) * | 2021-05-22 | 2021-08-10 | 韩艺 | Umbilical dropping liquid for losing weight and preparation method thereof |
| CN114869940A (en) * | 2022-03-29 | 2022-08-09 | 郗瑞席 | Traditional Chinese medicine composition, granules, water-bindered pills and method for treating hypertension, hyperlipidemia and hyperglycemia caused by obesity |
| CN114869940B (en) * | 2022-03-29 | 2023-03-31 | 郗瑞席 | A Chinese medicinal composition, granule, watered pill and preparation method thereof for treating obesity-induced type 2 diabetes, hypertension, hyperlipidemia and hyperuricemia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101961401B (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104509619B (en) | A kind of Chinese medical health slimming tea and preparation method thereof | |
| CN103251867A (en) | Chinese herbal compound medicine for treating diabetes mellitus and preparation method thereof | |
| CN102068707A (en) | Traditional Chinese medicine contrast medium adjuvant used for B ultrasonic and preparation method thereof | |
| CN101961401B (en) | Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying | |
| CN103463587A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN102138661A (en) | Formula and preparation method of beans capable of blackening hair | |
| CN103316279A (en) | Traditional Chinese medicine composition for treating chronic gastroenteritis | |
| CN110141632A (en) | A kind of rhizoma polygonati ball and preparation method thereof | |
| CN109847027A (en) | A kind of preparation process of Guben Huatan Chinese traditional medicines depressing lipid composition and its preparation | |
| CN105288340A (en) | Traditional Chinese medicine oral liquid for reducing weight and preparation method | |
| CN108143974A (en) | Relieving alcoholism and protecting liver ball | |
| CN107812105A (en) | A kind of medicine for treating kidney-yang deficiency and preparation method thereof | |
| CN105816750A (en) | Traditional Chinese medicine composition for treating qi-insufficiency constitution and traditional Chinese medicine conditioning paste | |
| CN102293964B (en) | Medicine for treating gastric ulcer, and preparation method thereof | |
| CN1660387A (en) | Health care preparation for regulating functional balance of organs of bowels in human body and preparing method | |
| CN104353051A (en) | Traditional Chinese medicine preparation for treating stomachache and preparation method thereof | |
| CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
| CN105056170A (en) | Application of traditional Chinese medicine composition in preparing drug for treating acute gastritis | |
| CN105343675A (en) | Traditional Chinese medicine preparation for treating adiposis and preparation method thereof | |
| CN101204565B (en) | Peroral Chinese traditional medicine prescripton for superficial gastritis | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN108721528A (en) | A kind of Chinese medicinal capsule for treating hypertension | |
| CN101829312A (en) | Medicament for treating rheumatoid arthritis and preparation method thereof | |
| CN107737292B (en) | Traditional Chinese medicine preparation for treating senile nocturia and preparation method thereof | |
| CN106075278A (en) | A kind of multi-functional Chinese medicine compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120509 Termination date: 20120907 |